March 16, 2017 / 11:32 PM / 5 months ago

BRIEF-CanniMed Q1 loss per share C$0.19 from continuing operations

March 16 (Reuters) - Cannimed Therapeutics Inc

* Cannimed therapeutics inc. Reports financial results for q1 2017

* Q1 loss per share c$0.19 from continuing operations

* Qtrly sales of $3.4 million were 93% higher than in same period of prior year Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below